propofol: All patients in this arm receive Propofol at a concentration of 10 mg/mL, administered via infusion at a dose of 1 mg/kg and completed within 5 minutes.
Dexmeditomidine: All subjects in this arm receive Dexmedetomidine with a prepared concentration of 10 μg/mL. A loading dose of 1.0 μg/kg is administered by infusion and completed within 10 minutes.
Esketamine: All subjects in this arm are given Esketamine at a prepared concentration of 5 mg/mL, infused at a dose of 0.5 mg/kg and completed within 10 minutes.
Study summary
This study aims to analyze the electroencephalographic power spectrum and connectivity during unresponsive states induced by propofol, esketamine and dexmedetomidine, respectively. It intends to explore the macro neural mechanisms underlying anesthetic unresponsiveness, so as to further elucidate the mechanisms by which anesthetics induce loss and recovery of consciousness. In addition, this study will identify neural biomarkers under general anesthesia for monitoring patients' actual intraoperative consciousness status. The findings will facilitate the development of monitoring indicators and devices reflecting intraoperative consciousness during general anesthesia, enabling more accurate assessment of patients' intraoperative consciousness status.
Eligibility
Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria:
* Patients scheduled for elective non-cardiac surgery;
* American Society of Anesthesiologists (ASA) physical status classification I-II;
* Aged 18 to 65 years, regardless of gender;
* Body mass index (BMI) greater than 18 kg/m² and no more than 31 kg/m²;
* Written informed consent voluntarily signed by the patient or legal authorized representative for participation in this study.
Exclusion Criteria:
Subjects meeting any one of the following items will be excluded from this study:
* Presence of severe cardiovascular diseases or hepatic and renal insufficiency;
* Hearing impairment;
* History of psychiatric disorders or communication disorders;
* Anticipated difficult airway;
* Pregnant or lactating women;
* History of allergic reaction or contraindication to any of the three anesthetic drugs used in this trial;
* Participation in other clinical trials within the past 3 months.
Primary outcome measure(s)
Permutation cross mutual information (PCMI) and PCMI-based brain networks — From baseline (awake) through loss of responsiveness to recovery of responsiveness EEG power spectrum \[broadband (0.1-45 Hz) and sub-band frequencies\] assessed by high-density EEG
EEG functional connectivity — From baseline (awake) through loss of responsiveness to recovery of responsiveness EEG functional connectivity assessed by high-density EEG
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy.